Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
K03861 is an inhibitor of cyclin-dependent kinase 2 (Cdk2).1 It binds to wild-type Cdk2, Cdk2C118L, Cdk2A144C, and Cdk2C118L/A144C (Kds = 50, 18.6, 15.4, and 9.7 nM, respectively). K03861 selectively inhibits the proliferation of IL-3-stimulated Ba/F3 cells expressing an FMS-related tyrosine kinase 3 bearing internal-tandem duplication (FLT3-ITD) over wild-type Ba/F3 cells (IC50s = ~0.001 and > 0.1 µM, respectively).2 It inhibits human cytomegalovirus replication in primary human monocyte-derived macrophages (IC50 = 1.028 µM).3 K03861 (10 µM) inhibits spindle organization and chromosome alignment in meiosis I and prevents egg activation in isolated mouse oocytes.4
WARNING This product is not for human or veterinary use.
1. Type II inhibitors targeting CDK2. ACS Chem. Biol. 10(9), 2116-2125 (2015).
2. Antileukemic effects of novel first-
3. Abemaciclib restricts HCMV replication by suppressing pUL97-
4. Transient inhibition of CDK2 activity prevents oocyte meiosis I completion and egg activation in mouse. J. Cell. Physiol. 237(11), 4317-4325 (2022).